Ken Griffin Becton Dickinson & CO Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Citadel Advisors LLC holds 160,900 shares of BDX stock, worth $36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

160,900

Previous 126,400 27.29%

Holding current value

$36 Million

Previous $29.5 Million 31.32%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $242 Million - $265 Million	-1,094,286 Reduced 74.64%	371,895 $89.7 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $113 Million - $124 Million	504,052 Added 52.39%	1,466,181 $343 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $65.1 Million - $69.1 Million	-279,010 Reduced 22.48%	962,129 $238 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $107 Million - $123 Million	-461,645 Reduced 27.11%	1,241,139 $303 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $79.3 Million - $88.2 Million	310,910 Added 22.34%	1,702,784 $440 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $111 Million - $124 Million	-467,229 Reduced 25.13%	1,391,874 $367 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $10 Million - $11.3 Million	43,589 Added 2.4%	1,859,103 $460 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $322 Million - $379 Million	1,475,075 Added 433.29%	1,815,514 $462 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $1.16 Million - $5.98 Million	-22,635 Reduced 6.23%	340,439 $75.9 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $79.4 Million - $93.2 Million	338,245 Added 1362.3%	363,074 $89.5 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $2.36 Million - $2.62 Million	9,694 Added 64.05%	24,829 $6.61 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $8.65 Million - $9.43 Million	-37,595 Reduced 71.3%	15,135 $3.71 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $1.64 Million - $1.8 Million	7,035 Added 15.4%	52,730 $13 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $7.59 Million - $8.3 Million	-32,616 Reduced 41.65%	45,695 $10.8 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $55.9 Million - $61.8 Million	-240,672 Reduced 75.45%	78,311 $19 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $17.1 Million - $18.9 Million	76,980 Added 31.81%	318,983 $79.8 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $188 Million - $241 Million	-870,556 Reduced 78.25%	242,003 $56.3 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $243 Million - $291 Million	1,105,408 Added 15458.09%	1,112,559 $266 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $4.62 Million - $5.21 Million	-19,539 Reduced 73.21%	7,151 $1.95 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $191 Million - $212 Million	-829,097 Reduced 96.88%	26,690 $6.59 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $175 Million - $199 Million	807,015 Added 1654.67%	855,787 $216 Million
Q4 2018 Feb 14, 2019	SELL	$204.73 - $257.93 $1.13 Million - $1.43 Million	-5,533 Reduced 10.19%	48,772 $10.7 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $126 Million - $138 Million	-540,484 Reduced 90.87%	54,305 $0
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $39.7 Million - $44.6 Million	-190,549 Reduced 24.26%	594,789 $0
Q1 2018 May 11, 2018	BUY	$205.46 - $240.27 $121 Million - $141 Million	586,830 Added 295.62%	785,338 $170 Million
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $7.5 Million - $8.83 Million	39,682 Added 24.98%	198,508 $42.5 Million
Q3 2017 Nov 09, 2017	BUY	$186.89 - $198.9 $29.7 Million - $31.6 Million	158,826	158,826 $31.1 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account